论文信息 - Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study - 字舞流文

Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

C. Wouters | M. Thomeer | P. Verhamme | A. Wilmer | T. Vanassche | B. de Tavernier | J. Wauters | J. Gunst | D. Mesotten | T. Fivez | L. Liesenborghs | C. Vandenbriele | D. Ruttens | D. Dauwe | P. Meersseman | G. Verbeke | M. Engelen | S. Tuyls | G. Van den Berghe | L. Heytens | Q. Van Thillo | S. Rex | I. Dapper

[1] C. Wouters,et al. A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study , 2020, Trials.